What does a global pandemic mean for the world’s drug supply chain? Howard Sklamberg, lawyer and former FDA deputy commissioner, talks to Dr. Josh Sharfstein about the threats that COVID-19 poses to medications for everything from cancer to diabetes to hypertension.
Published April 3, 2020
